Owing to the heterogeneous nature of ER+ breast cancer, the ER+ tumor mass demonstrated by ≥1% ER-positive stained tumor cells in immunohistochemistry (IHC) tests actually contains various amounts of ER-negative (ER−) cells [5]. The gene discussed is ESR1; the disease is neoplasm.